These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 15281017

  • 1. Improvement of glucose homeostasis in obese diabetic db/db mice given Plasmodium yoelii glycosylphosphatidylinositols.
    Elased KM, Gumaa KA, de Souza JB, Playfair JH, Rademacher TW.
    Metabolism; 2004 Aug; 53(8):1048-53. PubMed ID: 15281017
    [Abstract] [Full Text] [Related]

  • 2. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs).
    Elased KM, Gumaa KA, de Souza JB, Rahmoune H, Playfair JH, Rademacher TW.
    Mol Genet Metab; 2001 Jul; 73(3):248-58. PubMed ID: 11461192
    [Abstract] [Full Text] [Related]

  • 3. Reversal of type 2 diabetes in mice by products of malaria parasites: I. Effect of inactivated parasites.
    Elased KM, de Souza JB, Playfair JH.
    Metabolism; 2000 Jul; 49(7):937-41. PubMed ID: 10910007
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. (-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus.
    Freund P, Wolff HP, Kühnle HF.
    Metabolism; 1995 May; 44(5):570-6. PubMed ID: 7752903
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The possible role of age-related increase in the plasma glucagon/insulin ratio in the enhanced hepatic gluconeogenesis and hyperglycemia in genetically diabetic (C57BL/KsJ-db/db) mice.
    Kodama H, Fujita M, Yamazaki M, Yamaguchi I.
    Jpn J Pharmacol; 1994 Nov; 66(3):281-7. PubMed ID: 7869614
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
    Aoki K, Kikuchi T, Mukasa K, Ito S, Nakajima A, Satoh S, Okamura A, Sekihara H.
    Endocr J; 2000 Dec; 47(6):799-804. PubMed ID: 11228057
    [Abstract] [Full Text] [Related]

  • 10. Effects of the novel oral antidiabetic agent HQL-975 on glucose and lipid metabolism in diabetic db/db mice.
    Ishikawa Y, Watanabe K, Takeno H, Tani T.
    Arzneimittelforschung; 1998 Mar; 48(3):245-50. PubMed ID: 9553681
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Actions of the novel oral antidiabetic agent HQL-975 in genetically obese diabetic db/db mice.
    Ishikawa Y, Takagi Y, Takeno H, Watanabe K, Tani T.
    Biol Pharm Bull; 1998 Sep; 21(9):928-33. PubMed ID: 9781841
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
    Tanaka H, Nagashima T, Shimaya A, Urano Y, Shimokawa T, Shibasaki M.
    Eur J Pharmacol; 2010 Oct 25; 645(1-3):185-91. PubMed ID: 20655898
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glycosylphosphatidyl-inositols in murine malaria: Plasmodium yoelii yoelii.
    Kimmel J, Ogun SA, de Macedo CS, Gerold P, Vivas L, Holder AA, Schwarz RT, Azzouz N.
    Biochimie; 2003 Oct 25; 85(3-4):473-81. PubMed ID: 12770786
    [Abstract] [Full Text] [Related]

  • 18. Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats.
    Prasath GS, Pillai SI, Subramanian SP.
    Eur J Pharmacol; 2014 Oct 05; 740():248-54. PubMed ID: 25064342
    [Abstract] [Full Text] [Related]

  • 19. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice.
    Choi MS, Jung UJ, Yeo J, Kim MJ, Lee MK.
    Diabetes Metab Res Rev; 2008 Oct 05; 24(1):74-81. PubMed ID: 17932873
    [Abstract] [Full Text] [Related]

  • 20. Oral Supplementation with Benzylamine Delays the Onset of Diabetes in Obese and Diabetic db-/- Mice.
    Iffiú-Soltesz Z, Wanecq E, Tóthfalusi L, Szökő É, Carpéné C.
    Nutrients; 2021 Jul 29; 13(8):. PubMed ID: 34444782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.